Chimeric Antigen Receptor T Cell Therapy and the Kidney What the Nephrologist Needs to Know

被引：44
|
作者：
Jhaveri, Kenar D. [1 ]
Rosner, Mitchell H. [2 ]
机构：
[1] Hofstra Northwell, Zucker Sch Med, Div Kidney Dis & Hypertens, 100 Community Dr, Great Neck, NY 10021 USA
[2] Univ Virginia Hlth Syst, Dept Med, Div Nephrol, Charlottesville, VA USA
来源：
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2018年 / 13卷 / 05期
关键词：
CAR-T; onconephrology; drug nephrotoxicity; cytokines; adaptive cell transfer; chimeric receptor receptor therapy; MANAGEMENT; LEUKEMIA;
D O I：
10.2215/CJN.12871117
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：796 / 798
页数：3
相关论文
共 50 条
  • [31] The Cardiovascular Complications of Chimeric Antigen Receptor T Cell Therapy
    Faizi A. Jamal
    Samer K. Khaled
    Current Hematologic Malignancy Reports, 2020, 15 : 130 - 132
  • [32] Chimeric Antigen Receptor–Engineered T Cell Therapy in Lymphoma
    Paolo Strati
    Sattva S. Neelapu
    Current Oncology Reports, 2019, 21
  • [33] Chimeric Antigen Receptor (CAR) T Cell Therapy for Glioblastoma
    Feldman, Lisa
    Brown, Christine
    Badie, Behnam
    NEUROMOLECULAR MEDICINE, 2022, 24 (01) : 35 - 40
  • [34] Chimeric Antigen Receptor (CAR) T Cell Therapy for Glioblastoma
    Lisa Feldman
    Christine Brown
    Behnam Badie
    NeuroMolecular Medicine, 2022, 24 : 35 - 40
  • [35] Chimeric antigen receptor T cell therapy for autoimmune disease
    Chung, James B.
    Brudno, Jennifer N.
    Borie, Dominic
    Kochenderfer, James N.
    NATURE REVIEWS IMMUNOLOGY, 2024, 24 (11) : 830 - 845
  • [36] A Primer on Chimeric Antigen Receptor T-cell Therapy What Does It Mean for Pathologists?
    Cushman-Vokoun, Allison M.
    Voelkerding, Karl V.
    Fung, Mark K.
    Nowak, Jan A.
    Thorson, John A.
    Duncan, Helena L.
    Kalicanin, Tanja
    Anderson, Matthew W.
    Yohe, Sophia
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2021, 145 (06) : 704 - 716
  • [37] Chimeric Antigen Receptor T Cell Therapy for Acute Myeloid Leukemiachimeric Antigen Receptor T Cell Therapy for Acute Myeloid Leukemia
    Shrestha, Bishwas
    Vishwasrao, Paresh
    Li, Gongbo
    Ghafoor, Tayyebb
    Davila, Marco L.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (03) : S96 - S97
  • [38] CHIMERIC ANTIGEN RECEPTOR T CELL (CAR-T) THERAPY IN CHILDREN
    Desai, Devarshi
    Aragon, Camila Gonzalez
    Pabon, Camila
    Sendi, Prithvi Raj
    Meyer, Keith
    Totapally, Balagangadhar
    CRITICAL CARE MEDICINE, 2024, 52
  • [39] Role of bridging therapy during chimeric antigen receptor T cell therapy
    Bhaskar, Shakthi T.
    Dholaria, Bhagirathbhai R.
    Sengsayadeth, Salyka M.
    Savani, Bipin N.
    Oluwole, Olalekan O.
    EJHAEM, 2022, 3 : 39 - 45
  • [40] ACUTE KIDNEY INJURY AND ELECTROLYTE DERANGEMENTS AFTER CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY
    Morales, Erin
    Angelo, Joseph
    Ahmed, Nabil
    Doherty, Erin
    Yassine, Khaled
    Sinno, Mohamad
    Steffin, David
    Hsieh, Emily
    John, Tami
    Sasa, Ghadir
    Friend, Brian
    Salem, Baheyeldin
    Craddock, John
    Hegde, Meenakshi
    Omer, Bilal
    Heczey, Andras
    Martinez, Cardidad
    Heslop, Helen
    Rouce, Rayne
    Krance, Robert
    Bhar, Saleh
    PEDIATRIC BLOOD & CANCER, 2021, 68 : S104 - S104
12345